MeiraGTx Holdings PLC (MGTX)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$4.70
Buy
$5.28
$0.04 (+0.79%)
Prices updated at 23 May 2025, 21:04 EDT
| Prices minimum 15 mins delay
Prices in USD
MeiraGTx Holdings PLC is a clinical stage gene therapy company. Its pipeline products include AAV-CNGB3, AAV-CNGA3. AAV-UPF1, West AMD, Dry AMD, and others. Geographically, the company generates a majority of its revenue from the United Kingdom.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
In the news
Sharecast service unavailable
Press releases
Key dates
| Forecast date | |
|---|---|
| Annual report | Mar 2026 |
| Final results | Mar 2026 |
| Half yearly results | Aug 2025 |
| Annual general meeting | Jun 2025 |
| Previous date | |
|---|---|
| Annual report | Mar 2025 |
| Final results | Mar 2025 |
| Half yearly results | Aug 2024 |
| Annual general meeting | Jun 2024 |
Company reports
31 Dec 2023
Annual Report 30 Sep 2023
Quarterly Report 